SuperworthZevra Therapeutics market cap ZVRA
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $582.6M
- Highest close in our data
- $826.4M
- Jul 2026
Zevra Therapeutics is worth $582.6M at the close on Oct 23, 2026, at $9.81 a share.
That is down 2% over the last year and up 74% over five years.
Its highest close in our data was $826.4M in Jul 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $582.6M | $469.5M | $826.4M | +17% |
| 2025 | $499.4M | $373.4M | $685.1M | +12% |
| 2024 | $447.8M | $178.3M | $511.9M | +89% |
| 2023 | $237.2M | $142.7M | $237.2M | +50% |
| 2022 | $158.4M | $141.1M | $304.8M | −49% |
| 2021 | $307.6M | $25.4M | $416.8M | +506% |
| 2020 | $50.8M | $10.1M | $84.9M | +266% |
| 2019 | $13.9M | $10.6M | $73.7M | −71% |
| 2018 | $47.6M | $37.7M | $115.8M | −20% |
| 2017 | $59.4M | $39.6M | $71.8M | +37% |
| 2016 | $43.2M | $43.2M | $268.2M | −85% |
| 2015 | $287M | $202.6M | $336.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Zevra Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| ZVRAZevra Therapeutics | $582.6M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PBYIPuma Biotechnology | $568.9M |
| CRMDCorMedix | $611.9M |
| ARVNArvinas | $477.3M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| Peer median | $789.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Zevra Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.